Zobrazeno 1 - 10
of 267
pro vyhledávání: '"Pegylated Interferon Alfa"'
Autor:
Long Wang, Ni Lin, Yanfang Zhang, Shaoying Guo, Can Liu, Caorui Lin, Yongbin Zeng, Wennan Wu, Jianhui Guo, Chenggong Zhu, Fuguo Zhan, Qishui Ou, Zhen Xun
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT Objectives: Pegylated interferon alfa (PegIFNα) has limited efficacy in patients with chronic hepatitis B (CHB). Because single-nucleotide polymorphisms (SNPs) are known to confer disease susceptibility and influence treatment response, we
Externí odkaz:
https://doaj.org/article/af22a597478340ea9ee37a314c514dc0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
IDCases, Vol 21, Iss , Pp e00837- (2020)
The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satis
Externí odkaz:
https://doaj.org/article/ba530b11c12e41e2828cb01c42c810b1
Autor:
Marisa Boff Costa, Paulo Dornelles Picon, Guilherme Becker Sander, Hugo Nodarse Cuni, Carmen Valenzuela Silva, Rolando Páez Meireles, Ana Carolina Magalhães Andrade Góes, Nadia Maria Batoreu, Maria de Lourdes de Sousa Maia, Elizabeth Maciel Albuquerque, Denise Cristina de Souza Matos, Pedro Lopez Saura
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Several countries have used pegylation technology to improve the pharmacokinetic properties of essential drugs. Recently, a novel interferon alfa-2b protein conjugated to four-branched 12 kDa polyethylene glycol molecules was deve
Externí odkaz:
https://doaj.org/article/ada7798ae8e14c05b74b5ec1fb74647d
Autor:
Ružić Maja, Fabri Milotka, Stojanoska Medić Milica, Bajkin Ivana, Turkulov Vesna, Abenavoli Ludovico
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 145, Iss 1-2, Pp 43-48 (2017)
Introduction/Objective. Despite sufficiently explained pathogenesis, today autoimmune thyroid diseases (AITD) are recognized as one of extra-hepatic manifestations of systemic hepatitis C virus infection. The aim of the present study was to determine
Externí odkaz:
https://doaj.org/article/c9a9f3e796244d7ab7f3025260573238
Publikováno v:
International Journal of Advanced Research in Medicine. 3:270-273
Background: Pharmacological therapies of proven efficacy in corona virus disease 2019 are still lacking with no proven antiviral treatment. Impaired type I interferon activity may be responsible for severe disease in COVID-19 patient. We performed pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5db5fc276f3c015d61a403166986a9ed
https://doi.org/10.22271/27069567.2021.v3.i2e.254
https://doi.org/10.22271/27069567.2021.v3.i2e.254
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Hepatology, Vol 13, Iss 6, Pp 753-761 (2014)
Background/Purpose. Hepatitis C (HCV) is a major cause of morbidity and mortality in haemophilia patients who received clotting factor concentrates before the availability of virus-inactivated factors in the mid-1980s. Recently, it has been suggested
Externí odkaz:
https://doaj.org/article/9fe060ae247c4b7db303186e7a18a32c
Autor:
O. O. Znoyko, M. V. Maevskaya, E. A. Klimova, S. L. Maksimov, S. N. Kizhlo, N. A. Petrochenkova, F. I. Nagimova, R. A. Ivanov, Yu. N. Linkova, T. V. Chernovskaya
Publikováno v:
Журнал инфектологии, Vol 5, Iss 1, Pp 83-90 (2014)
Algeron (cepeginterferon alfa-2b) is a new pegylated form of interferon alfa containing linear polyethylene glycol (molecular weight 20 kDa). Pharmacokinetic profile of Algeron allows once weekly administration. In phase II–III study 150 treatment-
Externí odkaz:
https://doaj.org/article/8309c85f05cb4ce69fe7e97dad55ad44